Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling

Histone deacetylase (HDAC) inhibitors are efficacious epigenetic-based therapies for some cancers and neurological disorders; however, each of these drugs inhibits multiple HDACs and has detrimental effects on the skeleton. To better understand how HDAC inhibitors affect endochondral bone formation,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Signal
Autors principals: Carpio, Lomeli R., Bradley, Elizabeth W., McGee-Lawrence, Meghan E., Weivoda, Megan M., Poston, Daniel D., Dudakovic, Amel, Xu, Ming, Tchkonia, Tamar, Kirkland, James L., van Wijnen, Andre J., Oursler, Merry Jo, Westendorf, Jennifer J.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5409103/
https://ncbi.nlm.nih.gov/pubmed/27507649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.aaf3273
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars